$ASEP Making Huge Moves Today +26% ASEP Medical Holdings $ASEP/$ASEP.C is making huge moves today. Currently up 26% on the day, $ASEP has made a total gain of 75% in the last 3 weeks.
Prices still haven’t been able to reach IPO levels, but if they can make it back up there we’ll be looking at a gain of 130%.
$ASEP currently has 2 products in development. Aiming to resolve current issues with diagnosis and treatment of sepsis and antibiotic-resistant infections, $ASEP’s products aim to deliver faster results and better treatment.
$ASEP’s diagnostic assay for identifying sepsis infections is currently in pre-clinical development. The diagnostic tool has proven to provide reliable sepsis diagnosis in a fraction of the time as traditional methods, potentially saving thousands of lives through early diagnosis.
$ASEP is also currently in the process of developing a proprietary peptide technology that directly addresses current treatment issues for antibiotic-resistant biofilm infections. The technologies in development actively suppress biofilm growth and reduce inflammation.
With prices of $ASEP currently making big moves, news regarding the development of these two products could provide a strong catalyst to send shares skyrocketing. As the global antibiotics market is currently valued at $41.9 billion and is expected to grow at a CAGR of 3%, the subset of sepsis treatments within this market is valued at $1.0 billion and is expected to grow at a much larger CAGR of 8.5%. This represents a massive growth opportunity for $ASEP. Capturing just a small share of this market would equate to a huge growth opportunity for $ASEP from its current market cap of $36.48 million.
$ASEP is currently trading at $.76 and is valued at an MCAP of $42.66 million.
https://asepmedical.com/investors/